Angiotensin II (5-8), human is an endogenous C-terminal fragment of the peptide vasoconstrictor angiotensin II. Angiotensin II binds the AT II type 1 (AT1) receptor, stimulating GPCRs in vascular smooth muscle cells and increasing intracellular Ca2+ levels. Angiotensin II also acts at the Na+/H+ exchanger in the proximal tubules of the kidney.
CAT No: R1202
CAS No:34233-50-6
Synonyms/Alias:Angiotensin I/II (5-8);34233-50-6;Angiotensin II (5-8), human;Angiotensin (5-8);(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid;CTK1B7855;MFCD00167499;Angiotensin-(5-8);DTXSID40430963;CHEBI:144396;HY-P1769;Angiotensin I/II (5-8) TFA salt;FA109100;MS-29518;CS-0095581;C20972;G12438;Angiotensin I/II (5-8) (H-Ile-His-Pro-Phe-OH);H-Ile-His-Pro-Phe-OH TFA salt; H-IHPF-OH TFA salt;
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More